146 related articles for article (PubMed ID: 33906864)
1. Host IL11 Signaling Suppresses CD4
Huynh J; Baloyan D; Chisanga D; Shi W; O'Brien M; Afshar-Sterle S; Alorro M; Pang L; Williams DS; Parslow AC; Thilakasiri P; Eissmann MF; Boon L; Masson F; Chand AL; Ernst M
Cancer Immunol Res; 2021 Jul; 9(7):735-747. PubMed ID: 33906864
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer.
Nishina T; Deguchi Y; Ohshima D; Takeda W; Ohtsuka M; Shichino S; Ueha S; Yamazaki S; Kawauchi M; Nakamura E; Nishiyama C; Kojima Y; Adachi-Akahane S; Hasegawa M; Nakayama M; Oshima M; Yagita H; Shibuya K; Mikami T; Inohara N; Matsushima K; Tada N; Nakano H
Nat Commun; 2021 Apr; 12(1):2281. PubMed ID: 33863879
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration.
Xiong W; Chen Y; Zhang C; Li J; Huang H; Zhu Y; Deng G; Cheng J; Lin Y; Shi Z; Mou T
J Transl Med; 2023 Jun; 21(1):416. PubMed ID: 37365574
[TBL] [Abstract][Full Text] [Related]
5. Xenopus laevis il11ra.L is an experimentally proven interleukin-11 receptor component that is required for tadpole tail regeneration.
Suzuki S; Sasaki K; Fukazawa T; Kubo T
Sci Rep; 2022 Feb; 12(1):1903. PubMed ID: 35115663
[TBL] [Abstract][Full Text] [Related]
6. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
[TBL] [Abstract][Full Text] [Related]
7. Colitis-induced IL11 promotes colon carcinogenesis.
Wang H; Wang DH; Yang X; Sun Y; Yang CS
Carcinogenesis; 2021 Apr; 42(4):557-569. PubMed ID: 33196831
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis.
Ng B; Widjaja AA; Viswanathan S; Dong J; Chothani SP; Lim S; Shekeran SG; Tan J; McGregor NE; Walker EC; Sims NA; Schafer S; Cook SA
Sci Rep; 2021 Jul; 11(1):14088. PubMed ID: 34239012
[TBL] [Abstract][Full Text] [Related]
9. Critical Conditions for Studying Interleukin-11 Signaling In Vitro and Avoiding Experimental Artefacts.
Viswanathan S; Ng B; Widjaja AA; Pua CJ; Tham N; Tan J; Cook SA; Schafer S
Curr Protoc; 2021 Sep; 1(9):e251. PubMed ID: 34570432
[TBL] [Abstract][Full Text] [Related]
10. G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets.
Karagiannidis I; Jerman SJ; Jacenik D; Phinney BB; Yao R; Prossnitz ER; Beswick EJ
Front Immunol; 2020; 11():1885. PubMed ID: 33042110
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome.
Lim WW; Dong J; Ng B; Widjaja AA; Xie C; Su L; Kwek XY; Tee NGZ; Jian Pua C; Schafer S; Viswanathan S; Cook SA
Circ Res; 2022 Mar; 130(5):728-740. PubMed ID: 35135328
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH.
Dong J; Viswanathan S; Adami E; Singh BK; Chothani SP; Ng B; Lim WW; Zhou J; Tripathi M; Ko NSJ; Shekeran SG; Tan J; Lim SY; Wang M; Lio PM; Yen PM; Schafer S; Cook SA; Widjaja AA
Nat Commun; 2021 Jan; 12(1):66. PubMed ID: 33397952
[TBL] [Abstract][Full Text] [Related]
13. Repurposing the selective estrogen receptor modulator
Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
[TBL] [Abstract][Full Text] [Related]
14. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
[TBL] [Abstract][Full Text] [Related]
16. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
18. IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice.
Menkhorst E; Salamonsen L; Robb L; Dimitriadis E
Biol Reprod; 2009 May; 80(5):920-7. PubMed ID: 19144959
[TBL] [Abstract][Full Text] [Related]
19. IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts.
Adami E; Viswanathan S; Widjaja AA; Ng B; Chothani S; Zhihao N; Tan J; Lio PM; George BL; Altunoglu U; Ghosh K; Paleja BS; Schafer S; Reversade B; Albani S; Ling ALH; O'Reilly S; Cook SA
Rheumatology (Oxford); 2021 Dec; 60(12):5820-5826. PubMed ID: 33590875
[TBL] [Abstract][Full Text] [Related]
20. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells.
Onnis B; Fer N; Rapisarda A; Perez VS; Melillo G
J Clin Invest; 2013 Apr; 123(4):1615-29. PubMed ID: 23549086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
